A Pilot Study of ReNu Hip Injection: Monitoring the Response of Hip Function and Pain in Patient With Osteoarthritis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 30 Jul 2018
At a glance
- Drugs Amniotic cell therapy-NuCel (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Nutech Medical
- 20 Jul 2018 Planned primary completion date changed from 1 May 2018 to 1 May 2019.
- 20 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 02 Apr 2018 Planned End Date changed from 1 Dec 2018 to 1 Aug 2019.